FibroBiologics, Inc. (FBLG)
0.95
-0.07
(-6.86%)
USD |
NASDAQ |
Oct 23, 16:00
0.9643
+0.01
(+1.51%)
After-Hours: 20:00
FibroBiologics Price to Book Value : 1.246 for Oct. 23, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 23, 2026 | 1.246 |
| October 22, 2026 | 1.338 |
| October 21, 2026 | 1.302 |
| October 20, 2026 | 1.206 |
| October 19, 2026 | 1.238 |
| October 16, 2026 | 1.274 |
| October 15, 2026 | 1.312 |
| October 14, 2026 | 1.246 |
| October 13, 2026 | 1.259 |
| October 12, 2026 | 1.312 |
| October 09, 2026 | 1.482 |
| October 08, 2026 | 1.456 |
| October 07, 2026 | 1.495 |
| October 06, 2026 | 1.482 |
| October 05, 2026 | 1.548 |
| October 02, 2026 | 1.626 |
| October 01, 2026 | 1.580 |
| September 30, 2026 | 1.705 |
| September 29, 2026 | 1.718 |
| September 28, 2026 | 1.784 |
| September 25, 2026 | 1.823 |
| September 24, 2026 | 1.784 |
| September 23, 2026 | 1.744 |
| September 22, 2026 | 1.758 |
| September 21, 2026 | 1.784 |
| Date | Value |
|---|---|
| September 18, 2026 | 1.876 |
| September 17, 2026 | 1.948 |
| September 16, 2026 | 1.876 |
| September 15, 2026 | 1.889 |
| September 14, 2026 | 2.033 |
| September 11, 2026 | 2.112 |
| September 10, 2026 | 2.269 |
| September 09, 2026 | 2.308 |
| September 08, 2026 | 2.243 |
| September 04, 2026 | 2.374 |
| September 03, 2026 | 2.308 |
| September 02, 2026 | 2.558 |
| September 01, 2026 | 2.768 |
| August 31, 2026 | 2.256 |
| August 28, 2026 | 1.889 |
| August 27, 2026 | 1.954 |
| August 26, 2026 | 1.849 |
| August 25, 2026 | 1.836 |
| August 24, 2026 | 1.771 |
| August 21, 2026 | 1.889 |
| August 20, 2026 | 1.692 |
| August 19, 2026 | 1.561 |
| August 18, 2026 | 1.495 |
| August 17, 2026 | 1.338 |
| August 14, 2026 | 1.390 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 2.599 |
| Alnylam Pharmaceuticals, Inc. | 22.13 |
| Anika Therapeutics, Inc. | 2.088 |
| Savara, Inc. | 6.034 |
| Vericel Corp. | 5.881 |
Price to Book Value Related Metrics
| PEG Ratio | -0.0059 |
| Price | 0.95 |
| Earnings Yield | -593.7% |
| Market Cap | 5.777M |
| PEGY Ratio | -0.0059 |